160 related articles for article (PubMed ID: 35095844)
1. Tim-3 Relieves Experimental Autoimmune Encephalomyelitis by Suppressing MHC-II.
Tang L; Li G; Zheng Y; Hou C; Gao Y; Hao Y; Gao Z; Mo R; Li Y; Shen B; Wang R; Wang Z; Han G
Front Immunol; 2021; 12():770402. PubMed ID: 35095844
[TBL] [Abstract][Full Text] [Related]
2. The influence of T cell Ig mucin-3 signaling on central nervous system autoimmune disease is determined by the effector function of the pathogenic T cells.
Lee SY; Goverman JM
J Immunol; 2013 May; 190(10):4991-9. PubMed ID: 23562810
[TBL] [Abstract][Full Text] [Related]
3. Tim-3 Promotes Listeria monocytogenes Immune Evasion by Suppressing Major Histocompatibility Complex Class I.
Wang Z; Li G; Dou S; Zhang Y; Liu Y; Zhang J; Li G; Hou C; Wang R; Shen B; Han G
J Infect Dis; 2020 Feb; 221(5):830-840. PubMed ID: 31586389
[TBL] [Abstract][Full Text] [Related]
4. The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease.
Stüve O; Youssef S; Slavin AJ; King CL; Patarroyo JC; Hirschberg DL; Brickey WJ; Soos JM; Piskurich JF; Chapman HA; Zamvil SS
J Immunol; 2002 Dec; 169(12):6720-32. PubMed ID: 12471103
[TBL] [Abstract][Full Text] [Related]
5. Peripheral Injection of Tim-3 Antibody Attenuates VSV Encephalitis by Enhancing MHC-I Presentation.
Li G; Tang L; Hou C; Wang Z; Gao Y; Dou S; Mo R; Hao Y; Gao Z; Li Y; Dong J; Zhang J; Shen B; Wang R; Han G
Front Immunol; 2021; 12():667478. PubMed ID: 34025669
[TBL] [Abstract][Full Text] [Related]
6. T cell immunoglobulin and mucin domain protein 3 inhibits glycolysis in RAW 264.7 macrophages through Hexokinase 2.
Zhang J; Hou C; Dou S; Li G; Wang Z; Liu Y; Zhang Y; Wang R; Shen B; Han G
Scand J Immunol; 2021 Feb; 93(2):e12981. PubMed ID: 33031600
[TBL] [Abstract][Full Text] [Related]
7. CIITA promoter I CARD-deficient mice express functional MHC class II genes in myeloid and lymphoid compartments.
Zinzow-Kramer WM; Long AB; Youngblood BA; Rosenthal KM; Butler R; Mohammed AU; Skountzou I; Ahmed R; Evavold BD; Boss JM
Genes Immun; 2012 Jun; 13(4):299-310. PubMed ID: 22218223
[TBL] [Abstract][Full Text] [Related]
8. Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII.
Nikodemova M; Watters JJ; Jackson SJ; Yang SK; Duncan ID
J Biol Chem; 2007 May; 282(20):15208-16. PubMed ID: 17395590
[TBL] [Abstract][Full Text] [Related]
9. TRAIL-Mediated Suppression of T Cell Receptor Signaling Inhibits T Cell Activation and Inflammation in Experimental Autoimmune Encephalomyelitis.
Chyuan IT; Tsai HF; Wu CS; Sung CC; Hsu PN
Front Immunol; 2018; 9():15. PubMed ID: 29403497
[TBL] [Abstract][Full Text] [Related]
10. Effects of C2ta genetic polymorphisms on MHC class II expression and autoimmune diseases.
Yau AC; Piehl F; Olsson T; Holmdahl R
Immunology; 2017 Apr; 150(4):408-417. PubMed ID: 27861821
[TBL] [Abstract][Full Text] [Related]
11. Critical role of the tumor suppressor tuberous sclerosis complex 1 in dendritic cell activation of CD4 T cells by promoting MHC class II expression via IRF4 and CIITA.
Pan H; O'Brien TF; Wright G; Yang J; Shin J; Wright KL; Zhong XP
J Immunol; 2013 Jul; 191(2):699-707. PubMed ID: 23776173
[TBL] [Abstract][Full Text] [Related]
12. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Zheng H; Zhang H; Liu F; Qi Y; Jiang H
Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of CX3CR1 on autoimmune inflammation in a chronic EAE model for MS through modulation of antigen-presenting cell-related molecular MHC-II and its regulators.
Mai W; Liu X; Wang J; Zheng J; Wang X; Zhou W
Neurol Sci; 2019 Apr; 40(4):779-791. PubMed ID: 30671738
[TBL] [Abstract][Full Text] [Related]
14. Peripheral tolerance induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis.
Turley DM; Miller SD
J Immunol; 2007 Feb; 178(4):2212-20. PubMed ID: 17277126
[TBL] [Abstract][Full Text] [Related]
15. Bimodal regulation of T cell-mediated immune responses by TIM-4.
Mizui M; Shikina T; Arase H; Suzuki K; Yasui T; Rennert PD; Kumanogoh A; Kikutani H
Int Immunol; 2008 May; 20(5):695-708. PubMed ID: 18367551
[TBL] [Abstract][Full Text] [Related]
16. Amelogenin Downregulates Interferon Gamma-Induced Major Histocompatibility Complex Class II Expression Through Suppression of Euchromatin Formation in the Class II Transactivator Promoter IV Region in Macrophages.
Yotsumoto K; Sanui T; Tanaka U; Yamato H; Alshargabi R; Shinjo T; Nakao Y; Watanabe Y; Hayashi C; Taketomi T; Fukuda T; Nishimura F
Front Immunol; 2020; 11():709. PubMed ID: 32373130
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
[TBL] [Abstract][Full Text] [Related]
18. Tim-3 inhibits macrophage control of Listeria monocytogenes by inhibiting Nrf2.
Wang Z; Sun D; Chen G; Li G; Dou S; Wang R; Xiao H; Hou C; Li Y; Feng J; Shen B; Han G
Sci Rep; 2017 Feb; 7():42095. PubMed ID: 28205579
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide and KLF4 protein epigenetically modify class II transactivator to repress major histocompatibility complex II expression during Mycobacterium bovis bacillus Calmette-Guerin infection.
Ghorpade DS; Holla S; Sinha AY; Alagesan SK; Balaji KN
J Biol Chem; 2013 Jul; 288(28):20592-606. PubMed ID: 23733190
[TBL] [Abstract][Full Text] [Related]
20. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory.
Mortara L; Castellani P; Meazza R; Tosi G; De Lerma Barbaro A; Procopio FA; Comes A; Zardi L; Ferrini S; Accolla RS
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3435-43. PubMed ID: 16740768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
